Trial intelligence / Profile preview

Triamcinolone Acetonide in Alopecia Areata

IRCT20100314003566N10Phase 3Completed

Sponsor
Tabriz University of Medical Sciences
Start
Jan 2020
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, single-arm trial of triamcinolone acetonide in alopecia areata, sponsored by Tabriz University of Medical Sciences. Started Jan 2020; status: completed.

02

Drugs

triamcinolone acetonide
03

Conditions

alopecia areata

Beyond the preview

Go deeper on IRCT20100314003566N10.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20100314003566N10.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call